These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28899001)

  • 1. A role for autoantibodies in atherogenesis.
    Iseme RA; McEvoy M; Kelly B; Agnew L; Walker FR; Handley T; Oldmeadow C; Attia J; Boyle M
    Cardiovasc Res; 2017 Aug; 113(10):1102-1112. PubMed ID: 28899001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to the atheroma component beta2-glycoprotein I and risk of symptomatic peripheral artery disease.
    Franck M; Staub HL; Petracco JB; Norman GL; Lassen AJ; Schiavo N; Borges RB; von Mühlen CA
    Angiology; 2007; 58(3):295-302. PubMed ID: 17626983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auto-antibodies as possible markers and mediators of ischemic, dilated, and rhythmic cardiopathies.
    Satta N; Vuilleumier N
    Curr Drug Targets; 2015; 16(4):342-60. PubMed ID: 25429713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is atherosclerosis an autoimmune disease?
    Matsuura E; Atzeni F; Sarzi-Puttini P; Turiel M; Lopez LR; Nurmohamed MT
    BMC Med; 2014 Mar; 12():47. PubMed ID: 24642015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases.
    Carbone F; Nencioni A; Mach F; Vuilleumier N; Montecucco F
    Thromb Haemost; 2013 May; 109(5):854-68. PubMed ID: 23446994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is preclinical autoimmunity benign?: The case of cardiovascular disease.
    Majka DS; Chang RW
    Rheum Dis Clin North Am; 2014 Nov; 40(4):659-68. PubMed ID: 25437283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis in patients with autoimmune disorders.
    Frostegård J
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1776-85. PubMed ID: 15976324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral Immunity Against HDL Particle: A New Perspective in Cardiovascular Diseases?
    Satta N; Frias MA; Vuilleumier N; Pagano S
    Curr Pharm Des; 2019; 25(29):3128-3146. PubMed ID: 31470782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis -- an inception cohort study.
    Ajeganova S; de Faire U; Jogestrand T; Frostegård J; Hafström I
    J Rheumatol; 2012 Jun; 39(6):1146-54. PubMed ID: 22589258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
    Narshi CB; Giles IP; Rahman A
    Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prognostic value of IgM antibodies against phosphorylcholine for adverse cardiovascular events in patients with stable coronary heart disease.
    Imhof A; Koenig W; Jaensch A; Mons U; Brenner H; Rothenbacher D
    Atherosclerosis; 2015 Dec; 243(2):414-20. PubMed ID: 26520895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune and angiogenic biomarkers in autoimmune atherosclerosis.
    Balogh E; Pusztai A; Hamar A; Végh E; Szamosi S; Kerekes G; McCormick J; Biniecka M; Szántó S; Szűcs G; Nagy Z; Fearon U; Veale DJ; Szekanecz Z
    Clin Immunol; 2019 Feb; 199():47-51. PubMed ID: 30543922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease.
    Frostegård J
    Clin Immunol; 2010 Jan; 134(1):47-54. PubMed ID: 19748321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerosis and autoimmunity: a growing relationship.
    Sanjadi M; Rezvanie Sichanie Z; Totonchi H; Karami J; Rezaei R; Aslani S
    Int J Rheum Dis; 2018 May; 21(5):908-921. PubMed ID: 29671956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitus.
    El-Lebedy D; Rasheed E; Kafoury M; Abd-El Haleem D; Awadallah E; Ashmawy I
    J Diabetes Complications; 2016; 30(4):580-5. PubMed ID: 26965796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of human autoimmunity--autoantibodies versus autoimmune disease.
    Lleo A; Invernizzi P; Gao B; Podda M; Gershwin ME
    Autoimmun Rev; 2010 Mar; 9(5):A259-66. PubMed ID: 19963079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of immune complexes in atherogenesis.
    Burut DF; Karim Y; Ferns GA
    Angiology; 2010 Oct; 61(7):679-89. PubMed ID: 20395232
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.